Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journalSame Topic

Clinical indications and microscopic findings in 151 explanted intraocular lenses over 12 years.

Journal of cataract and refractive surgery·2026
Same author

Estimated Medicare Part D Ocular Drug Savings with a Direct-to-Consumer Pharmacy.

Ophthalmology·2026
Same author

Real-world data on toxic anterior segment syndrome.

Journal of cataract and refractive surgery·2026
Same author

Patient and caregiver perspectives on neurodevelopmental and mental health care for RASopathies.

Therapeutic advances in rare disease·2026
Same author

Long-Term Implant Cytology Evaluation of Explanted Intraocular Lenses Manufactured from Different Materials.

Journal of cataract and refractive surgery·2026
Same author

Assessment of calcification presence in hydrophilic acrylic phakic intraocular lenses.

Journal of cataract and refractive surgery·2026

Related Experiment Video

Updated: May 10, 2026

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
04:59

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Capsular bag opacification with a new accommodating intraocular lens.

Anne M Floyd1, Liliana Werner, Erica Liu

  • 1Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.

Journal of Cataract and Refractive Surgery
|July 9, 2013
PubMed
Summary

This study shows that an accommodating intraocular lens (IOL) with large haptic elements significantly reduces capsular bag opacification. The design appears to prevent posterior capsule opacification (PCO) and maintain capsular bag clarity.

More Related Videos

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
11:49

Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application

Published on: March 8, 2019

Related Experiment Videos

Last Updated: May 10, 2026

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
04:59

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
11:49

Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application

Published on: March 8, 2019

Area of Science:

  • Ophthalmology
  • Biomaterials Science
  • Medical Devices

Background:

  • Cataract surgery often involves intraocular lens (IOL) implantation.
  • Posterior capsule opacification (PCO) is a common complication after IOL surgery.
  • Accommodating IOLs aim to restore near vision but their biocompatibility and effect on PCO require evaluation.

Purpose of the Study:

  • To evaluate the biocompatibility and capsular bag opacification of an accommodating intraocular lens (IOL).
  • The study IOL features large haptic elements designed to separate the anterior and posterior capsules.
  • Assessing the impact of this IOL design on preventing capsular bag opacification.

Main Methods:

  • An experimental study was conducted using 6 New Zealand rabbits.
  • Bilateral phacoemulsification with IOL implantation was performed.
  • Each rabbit received a study accommodating IOL and a control 1-piece hydrophobic acrylic IOL, with evaluations up to 6 weeks postoperatively.

Main Results:

  • The study IOL group showed significantly lower mean posterior capsule opacification (PCO) clinical scores (0.5) compared to the control group (3.0) at 6 weeks (P=.001).
  • Anterior capsule opacification was minimal in the study group versus mild in the control group.
  • Histopathology confirmed no signs of toxicity in any eye, indicating good biocompatibility.

Conclusions:

  • The accommodating IOL with large haptic elements effectively maintained an expanded capsular bag.
  • This design appears to prevent capsular bag opacification, including posterior capsule opacification (PCO).
  • The study IOL demonstrates promising biocompatibility and reduced PCO, suggesting a potential benefit for cataract surgery outcomes.